Fol. Biol. 2018, 64, 186-194
https://doi.org/10.14712/fb2018064050186
Effects of Leukaemia Inhibitory Factor Receptor on the Early Stage of Osteogenic Differentiation of Human Bone Marrow Mesenchymal Cells
References
1. 2005) Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications. Foot Ankle Clin. 10, 651-665.
< , T. L. (https://doi.org/10.1016/j.fcl.2005.06.004>
2. 2001) Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp. Cell. Res. 268, 189-200.
< , F., Boynton, R. E., Liu, B., Murphy, J. M. (https://doi.org/10.1006/excr.2001.5278>
3. 2012) The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS One 7, e45142.
< , P., Schilling, T., Klein-Hitpass, L., Frey, S. P., Seefried, L., Raaijmakers, N., Krug, M., Regensburger, M., Zeck, S., Schinke, T., Amling, M., Ebert, R., Jakob, F. (https://doi.org/10.1371/journal.pone.0045142>
4. 2017) Serum from postmenopausal women treated with a by-product of oliveoil extraction process stimulates osteoblastogenesis and inhibits adipogenesis in human mesenchymal stem-cells (MSC). Exp. Gerontol. 90, 71-78.
< , A., Túnez-Fiñana, I., Mata-Granados, J. M., Ruiz- Méndez, M. V., Dorado, G., Romero-Sánchez, M.C., Navarro-Valverde, C., Quesada-Gómez, J. M. (https://doi.org/10.1016/j.exger.2017.01.024>
5. 2016) Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway. Cell Death Dis. 7, e2050.
< , M. Y., Sineva, G. S., Pospelov, V. A. (https://doi.org/10.1038/cddis.2015.387>
6. 2009) Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum. 60, 3356-3365.
Carbonare, L., Valenti, M. T., Zanatta, M., Donatelli, L., LoCascio, V. (
7. 2013) E-cadherin is required for the proper activation of the Lifr/Gp130 signaling pathway in mouse embryonic stem cells. Development 140, 1684-1692.
< , I., Rudloff, S., Carles, A., Li, Y., Liszewska, E., Vogt, R., Kemler, R. (https://doi.org/10.1242/dev.088690>
8. 1991) Murine recombinant leukemia inhibitory factor modulates inhibitory effect of 1,25 dihydroxyvitamin D3 on alkaline phosphatase activity in MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 175, 577-582.
< , Y., Sudo, T., Ishizuka, S., Tanaka, K., Higashino, K., Kusuda, M., Kodama, H., Kumegawa, M. (https://doi.org/10.1016/0006-291X(91)91604-B>
9. 2007) Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue. Eng. 13, 1799-1808.
< , M. N., Knippenberg, M., Klein-Nulend, J., Wuisman, P. I. (https://doi.org/10.1089/ten.2006.0165>
10. 2012) Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/ IGF1 pathway in murine multilineage cells. J. Bone Miner. Res. 27, 1566-15675.
< , E., Zhu, G., Jiang, W., Yang, K., Gao, Y., Luo, Q., Gao, J. L., Kim, S. H., Liu, X., Li, M., Shi, Q., Hu, N., Wang, L., Liu, H. (https://doi.org/10.1002/jbmr.1622>
11. 2015) Extracellular matrix stiffness regulates osteogenic differentiation through MAPK activation. PLoS One 10, e0135519.
< , J. H., Byun, M. R., Kim, A. R., Kim, K. M., Cho, H. J., Lee, Y. H., Kim, J., Jeong, M. G., Hwang, E. S., Hong, J. H. (https://doi.org/10.1371/journal.pone.0135519>
12. 2016) Tonsil-derived mesenchymal stem cells promote bone mineralization and reduce marrow and visceral adiposity in a mouse model of senile osteoporosis. Stem Cells Dev. 25, 251161-251171.
, Y. H., Park, M., Cho, K. A., Kim, B. K., Ryu, J. H., Woo, S. Y., Ryu, K. H. (
13. 2002) Leukemia inhibitory factor enhances bFGF-induced IL-6 synthesis in osteoblasts: involvement of JAK2/STAT3. Cell. Signal. 14, 311-315.
< , O., Otsuka, T., Uematsu, T. (https://doi.org/10.1016/S0898-6568(01)00248-0>
14. 2017) High glucose-induced LIF suppresses osteoblast differentiation via regulating STAT3/SOCS3 signaling. Cytokine 91, 132-139.
< , C., Jiang, D. (https://doi.org/10.1016/j.cyto.2016.12.016>
15. 2008) Changes in the expression of CD10 6, osteogenic genes, and transcription factors involved in the osteogenic differentiation of human bone marrow mesenchymal stem cells. J. Bone Miner. Metab. 26, 312-320.
< , F., Akiyama, Y., Tai, S., Maruyama, K., Kawaguchi, Y., Muramatsu, K., Yamaguchi, K. (https://doi.org/10.1007/s00774-007-0842-0>
16. 2017) Icariside II promotes the osteogenic differentiation of canine bone marrow mesenchymal stem cells via the PI3K/AKT/mTOR/S6K1 signaling pathways. Am. J. Transl. Res. 9, 2077-2087.
, G., Xu, B., Huang, Y. (
17. 2014) Calcium-sensing receptor-mediated osteogenic and early-stage neurogenic differentiation in umbilical cord matrix mesenchymal stem cells from a large animal model. PLoS One 9, e111533.
< , N. A., Reshkin, S. J., Ciani, E., Dell’Aquila, M. E. (https://doi.org/10.1371/journal.pone.0111533>
18. 1995) Leukemia inhibitory factor inhibits osteogenic differentiation in rat calvaria cell cultures. Endocrinology 136, 1411-1418.
< , L., Gupta, A. K., Aubin, J. E. (https://doi.org/10.1210/endo.136.4.7895651>
19. 2016) Small nuclear ribonucleoprotein polypeptide N (Sm51) promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating Runx2. Cell Tissue Res. 366, 155-162.
< , F., Xu, L., Huang, S., Liu, Y., Hou, Y., Wang, K., Jiang, X., Li, G. (https://doi.org/10.1007/s00441-016-2411-0>
20. 2015) Oncostatin- M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling. Neoplasia 17, 225-237.
< , K., Bhosale, D., Desai, A., Chandrika, G., Pujari, R., Jagtap, J., Chugh, A., Ranade, D., Shastry, P. (https://doi.org/10.1016/j.neo.2015.01.001>
21. 2015) Human mesenchymal stem cells retain multilineage differentiation capacity including neural marker expression after extended in vitro expansion. PLoS One 10, e0137255.
< , R. K., Camilleri, E. T., Oikari, L. E., Yu, C., Cool, S. M., van Wijnen, A. J., Griffiths, L. R., Haupt, L. M. (https://doi.org/10.1371/journal.pone.0137255>
22. 2013) Mass production of early-stage bone-marrow-derived mesenchymal stem cells of rat using gelatin-coated matrix. Biomed. Res. Int. 2013, 347618.
, Y. H., Yun, J. I., Han, N. R., Park, H. J., Ahn, J. Y., Kim, C., Choi, J. H., Lee, E., Lim, J. M., Lee, S. T. (
23. 2006) Receptor-mediated transport of LIF across blood-spinal cord barrier is upregulated after spinal cord injury. J. Neuroimmunol. 174, 119-125.
< , W., Cain, C., Yu, Y., Kastin, A. J. (https://doi.org/10.1016/j.jneuroim.2006.02.006>
24. 1998) Modulation of the activation status of Stat5a during LIF-induced differentiation of M1 myeloid leukemia cells. Biochim. Biophys. Acta 1402, 313-323.
< , R. P., Rinke, R., Gouilleux, F., Neumann, B., Groner, B., Hocke, G.M. (https://doi.org/10.1016/S0167-4889(98)00024-X>
25. 1995) Bone matrix proteins in osteogenesis and remodelling in the neonatal rat mandible as studied by immunolocalization of osteopontin, bone sialoprotein, α 2HS-glycoprotein and alkaline phosphatase. Arch. Oral. Biol. 40, 145-155.
< , G. J., Farach-Carson, M. C., Devoll, R. E., Aubin, J. E., Brunn, J. C., Butler, W.T. (https://doi.org/10.1016/0003-9969(94)00144-Z>
26. 1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
< , M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., Marshak, D. R. (https://doi.org/10.1126/science.284.5411.143>
27. 2003) Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor. J. Biol. Chem. 278, 27169-27179.
< , H., Perret, D., Diveu, C., Froger, J., Chevalier, S., Lelièvre, E., Gascan, H., Chabbert, M. (https://doi.org/10.1074/jbc.M303168200>
28. 2012) Foreword: interactions between bone and adipose tissue and metabolism. Bone 50, 429.
< , C., Karsenty, G., MacDougald, O. (https://doi.org/10.1016/j.bone.2011.10.006>
29. 2008) Comparative transcriptomics of human multipotent stem cells during adipogenesis and osteoblastogenesis. BMC Genomics 9, 340.
< , M., Elabd, C., Zaragosi, L. E., Chiellini, C., Hackl, H., Sanchez-Cabo, F., Yadav, S., Duszka, K., Friedl, G., Papak, C., Prokesch, A., Windhager, R., Ailhaud, G., Dani, C., Amri, E. Z., Trajanoski, Z. (https://doi.org/10.1186/1471-2164-9-340>
30. 2012) Leukemia inhibitory factor: a paracrine mediator of bone metabolism. Growth Factors 30, 76-87.
< , N. A., Johnson, R. W. (https://doi.org/10.3109/08977194.2012.656760>
31. 2015) Mechanical regulation of mesenchymal stem cell differentiation. J. Anat. 227, 717-731.
< , A. J., Kelly, D. J. (https://doi.org/10.1111/joa.12243>
32. 2012) Conditioned medium from bone marrow mesenchymal stem cells transiently retards osteoblast differentiation by downregulating runx2. Cells Tissues Organs 196, 510-522.
< , J., Zhou, H., Deng, Y., Zhang, Y., Gu, P., Ge, S., Fan, X. (https://doi.org/10.1159/000339245>
33. 2014) The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/ leukemia inhibitory factor receptor (LIFR). J. Biol. Chem. 289, 18442-184450.
< , E. M., Aurich, M., Aparicio-Siegmund, S., Floss, D. M., Garbers, C., Breusing, K., Rabe, B., Schwanbeck, R., Grötzinger, J., Rose-John, S., Scheller, J. (https://doi.org/10.1074/jbc.M114.568857>